Target intelligence / Profile preview

Cold shock domain-containing protein C2 (CSDC2)

Target
CSDC2
Molecular classification
Other (RNA-binding protein), Other (Cold shock domain protein)
01

Overview

Cold shock domain-containing protein C2 (CSDC2) is an RNA-binding protein encoded by the *CSDC2* gene in humans[1][2][6][7]. It specifically binds to the 3'-UTR of certain mRNAs, such as those for histone H1 and H3.3, and is implicated in regulating mRNA stability and gene expression, including histone variant synthesis in the developing brain[1][2]. CSDC2 displays distinct subcellular localization associated with cellular differentiation and proliferation, for instance in the endometrium during decidualization[3][5]. Experimental evidence links altered CSDC2 expression to regulation of reproductive differentiation, hair follicle cycling in skin, and as part of RNA-binding protein signatures predictive of cancer recurrence, suggesting its potential as a disease biomarker[2]. No evidence identifies CSDC2 as a classical therapeutic target or receptor, nor are there known drugs or mechanisms of action directly targeting it[1][2][7].

Other names
PIPPinPIPPINRNA-binding protein PIPPinDJ347H13.2cold shock domain containing C2RNA-binding protein pippinCSDC2_HUMAN
02

Biological functions

RNA bindingmRNA 3'-UTR bindingRegulation of mRNA stabilityRegulation of gene expressionRegulation of histone variant synthesisPossible transcriptional regulation
03

Disease associations

Cancer (biomarker/prognostic contexts in prostate and colorectal cancer)Other (reproductive and developmental processes)Neurobiology (developing brain histone variant regulation)
04

Biomarkers

Expression signatures in prostate cancer recurrenceExpression in early-onset colorectal cancer

Beyond the preview

Go deeper on Cold shock domain-containing protein C2 (CSDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cold shock domain-containing protein C2 (CSDC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call